Dana-Farber Cancer reports robust operating income of $51M

Boston-based Dana-Farber Cancer Institute reported a slight increase in its operating income for the final three months of 2022, notching $51.6 million in the period as revenues grew 14.6 percent over the same period in 2021.

Read the full post at Becker's Hospital Review - Healthcare News